阿托伐他汀在我国的专利申请情况分析.pdfVIP

Chinese Journal of New D rugs 2011, 20( 15) , , (沈阳药科大学工商管理学院, 沈阳 110016) [] 文中介绍了阿托伐他汀的研究状况, 并提出药物开 的思路收集国家专利信息中心专利 数据库收录的阿托伐他汀专利申请信息, 按年代国别申请机构性质专利类型等项精细分类后进行统 计分析我国阿托伐他汀的研究起步相对较晚, 专利质量较低, 且专利技术主要集中在辉瑞和梯瓦这两 个公司等专利类型是 一重要分类项目, 可用来定性判断企业在相关专利技术方面的竞争力, 同时指导 国内药物开 [] 阿托伐他汀; 专利申请; 统计分析; 药物开 [] R 5 [] C [] 1003- 3734( 2011) 15- 1372- 05 Analysis of atorvastatin paten t app lication in Ch ina LIU Juan, DONG L,i GAO Jing-m ei (School of BusinessAdm inistration, Shenyang Pharmaceutical University, Shenyang 110016, China) [ Abstract] Th is paper introduced research status of atorvastatin and to put forw ard the ideas of drug deve-l opment. Information of atorvastatin patent applicationw as collected from patent database of national patent informa- tion centre. W e classify the information accord ing to year, country, app licant nature and patent type, and statist-i cally analyze the gathered data. Our country starts the research of atorvastatin relatively late; the patent quality of atorvastatin is low; and the patent technology of atorvastatin is mainly concentrated in Pfizer and Teva. The patent type is an mi portant classification item, w hich can be used to determ ine the competitiveness of relative patent tech- nology qualitatively and gu ide domestic drug development. [K ey w ords] atorvastatin; patent application; statistical analysis; drug development , , , , , , , , , , Apotex , [] 刘娟, 女, 硕士研究